News Chart aTyr Pharma, Inc.

Equities

LIFE

US0021202025

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-17 EDT			5-day change	1st Jan Change
2 ^USD	+3.63%		+18.34%	+41.84%

05-14	ATyr Pharma, Inc. Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT? Study in Pulmonary Sarcoidosis	CI
05-02	ATyr Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

cbf734905c972bf74381fb4d.d-tPSXqJIzr6znMX8LtFB6uNcEC_U6C1CY2hIxYLpZc.NYkBM0O8aGC2phdEtYsjf9i0JzjXB5PdavnrYC975O0ygxslKOxHcLu3Mg~263a9c130bc335c29a6a6717e8ce1426